About: Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on May 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в травні 2008 (uk) مقالة علمية نشرت في مايو 2008 (ar) scientific article published on May 2008 (en)
publication date	wds:Q37216229-9BD39CBA-FBA7-4793-9812-B49B8D3816B0
publication date	2008-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37216229-4266ADDA-E7AE-4E64-B4FB-44476460A7C3
language of work or name	English
cites work	wds:Q37216229-02D904A2-8907-4C6F-A5E5-6AAD46C35CF7 wds:Q37216229-0663782B-AA23-484E-AE07-8FF3E262B7B3 wds:Q37216229-1ADD09F4-ECCE-4D21-BBA1-B63B4F0EFE88 wds:Q37216229-22D4B02D-67E5-49AB-AC46-2F92A68B0591 wds:Q37216229-2F5851CA-5ECF-4B93-917E-38C6CA6CB757 wds:Q37216229-4D2D3B9D-90A0-4F50-AC00-CDEE9FFE3DAF wds:Q37216229-4E3EDE68-3165-4001-A879-8499A7C046D5 wds:Q37216229-5113089E-2E5C-44E2-88C5-FE6FBB9735EB wds:Q37216229-5EA68F04-56CE-4D47-8344-AECD31029897 wds:Q37216229-6350E307-784C-484C-AF15-9FC13BAB162B wds:Q37216229-65C726B5-2ABD-4FC1-97B4-5D4CED3EEDFD wds:Q37216229-757287C7-0D80-4CCF-8303-3A84532206FF wds:Q37216229-7F50F0E6-A332-4C79-B909-0211D1005F6A wds:Q37216229-89FF59E6-18BD-46CC-BD3A-72E0137AA47F wds:Q37216229-98ACB456-976C-4CFB-A975-BC714D04C64C wds:Q37216229-9F1415BE-5BE1-4128-AF00-49830E4DA1B0 wds:Q37216229-A73E814A-E332-4637-B10E-1B94DF1CC979 wds:Q37216229-AA202305-DDCF-486A-AD3B-2F4BC581E025 wds:Q37216229-BF5783D1-FC9F-4A89-B832-409F9CDEE858 wds:Q37216229-C844FE59-EE7A-4A05-B6EC-8A09EF96A63B wds:Q37216229-D591EACF-F08B-4DC8-9041-AEA82727DE5B wds:Q37216229-D6235D19-4741-4094-B6EE-E5D166677637 wds:Q37216229-DCF020A5-DEA8-4A33-AFB1-5AA3CAC0D0CA wds:Q37216229-EA690813-A2CA-4356-8123-6FF531506513 wds:Q37216229-F964FEF1-37BD-4C3C-A095-DC3AFF4072C5 wds:Q37216229-F9DE7685-5411-42D6-81C5-D09885D669BE wds:Q37216229-FD289C2D-F7F5-4057-AFC9-171E9518CC20
cites work	Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance Paradoxes of adherence and drug resistance to HIV antiretroviral therapy Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration Antiretroviral therapy in a thousand patients with AIDS in Haiti Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Visual Analog Scale of ART Adherence High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients Measuring medication adherence: are missed doses reported more accurately then perfect adherence? Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa HIV-1 subtype C reverse transcriptase and protease genotypes in Zimbabwean patients failing antiretroviral therapy The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of pediatric AIDS clinical trials group prot Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients What policymakers should know about drug resistance and adherence in the context of scaling-up treatment of HIV infection High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1. Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi Extending antiretroviral therapy to resource-poor settings: implications for drug resistance Sequence variability of the HIV type 1 protease gene in thai patients experienced with antiretroviral therapy.
author name string	wds:Q37216229-1B93C406-AEB9-493B-ADEE-07EBC122C029 wds:Q37216229-24B36BE0-CC01-4633-A547-F3E3630C6C24 wds:Q37216229-3D87A525-66F2-4FCA-8B25-AC7DFAEAF8B6 wds:Q37216229-4A71E6AB-8601-47C7-A216-66700BB3BC28 wds:Q37216229-88AACEE5-A8A4-4A00-B773-A3DB0F915DFC wds:Q37216229-9758F407-BC39-4C61-B78C-63C2751D05E0 wds:Q37216229-A63C9F21-628A-465F-99C4-FD653706F77E wds:Q37216229-CA9224AD-8146-44CD-AB57-CB863FFC9898
author name string	Zhigang Lu Henry Sunpath Helga Holst Michelle Gordon Jane Hampton Steve Carpenter South Africa Resistance Cohort Study Team Kofi Koranteng-Apeagyei
rdfs:label	Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (en) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (nl) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (ast)
skos:prefLabel	Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (en) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (nl) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (ast)
name	Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (en) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (nl) Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa (ast)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software